← Open Payments lookup

MORGAN BAKER: Open Payments

NPI 1609400886 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$222 in 11 payments from 9 companies in 2025. Trend: 2023 $331 · 2024 $641 · 2025 $222

Food & beverage: $222
CompanyPaymentsAmount
Astellas Pharma US Inc3$64
Inspire Medical Systems, Inc.1$36
ABIOMED1$24
Otsuka America Pharmaceutical, Inc.1$20
ABBVIE INC.1$17
GlaxoSmithKline, LLC.1$16
Actelion Pharmaceuticals US, Inc.1$16
Boehringer Ingelheim Pharmaceuticals, Inc.1$15
Novo Nordisk Inc1$15

Products named: Veozah, INSPIRE, REXULTI, QULIPTA, TRELEGY ELLIPTA, OPSUMIT, JARDIANCE, Ozempic.

Industry payments across GA — which companies pay providers there.